Translational Development Acquisition (TDACW) Free Cash Flow Growth (1y) (2025 - 2026)
Powered by 
Analysis
Translational Development Acquisition (TDACW) Free Cash Flow Growth (1y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Evercore | 11.52 Bn | 9.43 Bn | 975.67 Mn | 25.04% |
| 2 | Jefferies Financial | 11.24 Bn | -4.17 Bn | 3.09 Bn | - |
| 3 | Houlihan Lokey | 9.53 Bn | 8.45 Bn | - | - |
| 4 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 5 | PJT Partners | 6.94 Bn | 6.99 Bn | 481.98 Mn | 26.53% |
| 6 | Moelis | 6.06 Bn | 5.99 Bn | - | 8.25% |
| 7 | Piper Sandler Companies | 5.20 Bn | 5.09 Bn | - | 58.77% |
| 8 | Lazard | 4.97 Bn | 3.99 Bn | - | 425.02% |
| 9 | BRBI BR Partners | 3.44 Bn | 3.32 Bn | 16.77 Mn | 241.39% |
| 10 | Translational Development Acquisition | 52.67 Mn | 52.58 Mn | - | -97.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -97.70% |
| Mar 31, 2026 | -31.78% |
| Dec 31, 2025 | 85.53% |